Centessa Pharmaceuticals plc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| MEDICXI VENTURES MANAGEMENT (JERSEY) LTD | 10/17/2025 | 19.96 M | $484.11 M | 0.00% | 14.93% |
| AVORO CAPITAL ADVISORS LLC | 11/14/2025 | 10.81 M | $262.10 M | 116.16% | 8.09% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2025 | 10.04 M | $243.35 M | 19.42% | 7.51% |
| INDEX VENTURE LIFE ASSOCIATES VI LTD | 11/14/2025 | 9.96 M | $241.57 M | 0.00% | 7.45% |
| GENERAL ATLANTIC, L.P. | 11/13/2025 | 9.68 M | $234.78 M | 0.00% | 7.24% |
| FMR LLC | 11/13/2025 | 6.28 M | $152.22 M | 64.06% | 4.70% |
| JANUS HENDERSON GROUP PLC | 11/14/2025 | 5.41 M | $131.08 M | -17.21% | 4.05% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 4.80 M | $116.50 M | -18.69% | 3.59% |
| FARALLON CAPITAL MANAGEMENT LLC | 11/14/2025 | 4.33 M | $105.03 M | -4.37% | 3.24% |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 11/14/2025 | 3.64 M | $88.17 M | -15.32% | 2.72% |
| SIREN, L.L.C. | 11/13/2025 | 3.23 M | $78.27 M | -6.72% | 2.41% |
| TCG CROSSOVER MANAGEMENT, LLC | 11/17/2025 | 3.14 M | $76.06 M | 8.50% | 2.35% |
| PERCEPTIVE ADVISORS LLC | 11/14/2025 | 3.10 M | $75.20 M | 170.36% | 2.32% |
| COMMODORE CAPITAL LP | 11/14/2025 | 2.85 M | $69.11 M | -13.59% | 2.13% |
| FRANKLIN RESOURCES INC | 11/13/2025 | 2.56 M | $62.04 M | 0.58% | 1.91% |
| RTW INVESTMENTS, LP | 11/14/2025 | 2.29 M | $55.57 M | 49.80% | 1.71% |
| CORMORANT ASSET MANAGEMENT, LP | 11/14/2025 | 1.93 M | $46.68 M | -7.74% | 1.44% |
| FEDERATED HERMES, INC. | 11/03/2025 | 1.75 M | $42.43 M | 100.00% | 1.31% |
| FORESITE CAPITAL MANAGEMENT VI LLC | 11/14/2025 | 1.31 M | $31.86 M | 4.84% | 0.98% |
| MORGAN STANLEY | 11/14/2025 | 1.12 M | $27.27 M | -37.30% | 0.84% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2025 | 1.11 M | $26.85 M | 23.00% | 0.83% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2025 | 1.10 M | $26.60 M | -3.01% | 0.82% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2025 | 1.07 M | $26.01 M | -58.61% | 0.80% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 902.27 K | $21.88 M | -45.58% | 0.68% |
| OCTAGON CAPITAL ADVISORS LP | 11/14/2025 | 830.00 K | $20.13 M | -19.42% | 0.62% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2025 | 805.61 K | $19.54 M | -34.05% | 0.60% |
| SATURN V CAPITAL MANAGEMENT LLC | 11/14/2025 | 734.54 K | $17.81 M | -7.41% | 0.55% |
| CAPITAL WORLD INVESTORS | 11/13/2025 | 684.81 K | $16.61 M | 64.29% | 0.51% |
| 5AM VENTURE MANAGEMENT, LLC | 11/14/2025 | 680.95 K | $16.51 M | -18.05% | 0.51% |
| PFM HEALTH SCIENCES, LP | 11/14/2025 | 666.20 K | $16.16 M | 93.12% | 0.50% |
| STEMPOINT CAPITAL LP | 11/14/2025 | 655.39 K | $15.89 M | -48.22% | 0.49% |
| TANAGER WEALTH MANAGEMENT LLP | 10/24/2025 | 598.04 K | $14.50 M | 0.00% | 0.45% |
| ENSIGN PEAK ADVISORS, INC | 11/13/2025 | 559.74 K | $13.57 M | 0.00% | 0.42% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 553.01 K | $13.41 M | 307.23% | 0.41% |
| ECOR1 CAPITAL, LLC | 11/14/2025 | 550.00 K | $13.34 M | 100.00% | 0.41% |
| LOGOS GLOBAL MANAGEMENT LP | 11/14/2025 | 525.00 K | $12.73 M | 100.00% | 0.39% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2025 | 515.98 K | $12.51 M | 1.02% | 0.39% |
| CAPTION MANAGEMENT, LLC | 11/14/2025 | 473.00 K | $11.47 M | 100.00% | 0.35% |
| TD ASSET MANAGEMENT INC | 11/10/2025 | 466.96 K | $11.32 M | -15.60% | 0.35% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 430.30 K | $10.43 M | 124.00% | 0.32% |
| BLACKROCK, INC. | 11/12/2025 | 408.39 K | $9.90 M | 7.15% | 0.31% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 11/14/2025 | 404.80 K | $9.82 M | -27.04% | 0.30% |
| ARMISTICE CAPITAL, LLC | 11/17/2025 | 378.00 K | $9.17 M | -5.50% | 0.28% |
| CANDRIAM S.C.A. | 11/06/2025 | 343.21 K | $8.32 M | -1.26% | 0.26% |
| CAPTION MANAGEMENT, LLC | 11/14/2025 | 330.60 K | $8.02 M | 1,016.89% | 0.25% |
| IKARIAN CAPITAL, LLC | 11/14/2025 | 307.70 K | $7.46 M | 53.85% | 0.23% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 11/14/2025 | 262.15 K | $6.36 M | -17.45% | 0.20% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 247.56 K | $6.00 M | -55.74% | 0.19% |
| ROYCE & ASSOCIATES LP | 11/12/2025 | 247.39 K | $6.00 M | 100.00% | 0.19% |
| JAIN GLOBAL LLC | 11/14/2025 | 241.98 K | $5.87 M | 100.00% | 0.18% |
Centessa Pharmaceuticals plc institutional Ownership - FAQ's
During the previous two years, 147 institutional investors and hedge funds held shares of Centessa Pharmaceuticals plc. The most heavily invested institutionals were:
Medicxi Ventures Management (Jersey) Ltd: 19.96 M
Avoro Capital Advisors LLC: 10.81 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 10.04 M
Index Venture Life Associates VI Ltd: 9.96 M
GENERAL ATLANTIC, L.P.: 9.68 M
FMR LLC: 6.28 M
96.00% of Centessa Pharmaceuticals plc stock is owned by institutional investors.
Institutional investors have bought a total of 132.21 M shares in the last 24 months. This purchase volume represents approximately $3.07 B in transactions.